110405 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Human Immunodeficiency Virus, HIV Methods of production or purification of viral material
Sub-classes:COMPOSITIONS AND METHODS FOR PREPARING VIRAL VECTORS
#2COMPOSITIONS FOR MAINTAINING LENTIVIRAL VECTOR AND USES THEREOF
#3HIV GP41 VARIANTS FOR IMMUNODIAGNOSTIC ASSAYS
#4SYNCITIN-1 FUSION PROTEINS AND USES THEREOF FOR CARGO DELIVERY INTO TARGET CELLS
#5SERUM-FREE SUSPENSION SYSTEM FOR LENTIVIRAL PRODUCTION
#6METHOD FOR LARGE-SCALE PRODUCTION OF LENTIVIRUS BY USING GMP-LEVEL SERUM-FREE SUSPENSION CELLS
#7Purification Method of Viral Vectors
#8VIRAL ANTIGEN DISPLAY COMPOSITIONS AND METHODS
#9LENTIVIRAL VECTOR TECHNOLOGY FOR INNER EAR GENE THERAPY
#10VECTOR MANUFACTURING PROCESSES
#11Conformationally Specific Viral Immunogens
#12PROGRAMMED DNA-DRIVEN SELF-ASSEMBLED RNA HYDROGEL
#13LIMITING VIRAL INFECTION AND REPLICATION IN STEM CELLS
#14COMPOSITIONS AND METHODS FOR PRODUCING AND OPTIMIZING VIRAL VECTOR PRODUCER CELLS FOR CELL AND GENE THERAPY
#15Method for large-scale production of lentivirus by using GMP-level serum-free suspension cells
#16Vaccine
#17Retroviral vector
#18Digital-to-analog conversion apparatus and method having signal calibration mechanism
#19Production System
#20SERUM-FREE SUSPENSION SYSTEM FOR LENTIVIRAL PRODUCTION
#21COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A CELL COMPRISING TRIAZOLE COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR APPLICATIONS
#22SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS
#23Method for large-scale production of lentivirus by using GMP-level serum-free suspension cells
#24COMPOSITIONS AND METHODS FOR PREPARING VIRAL VECTORS
#25Conformationally-specific viral immunogens
#26RETROVIRAL PARTICLE COMPRISING AT LEAST TWO ENCAPSIDATED NONVIRAL RNAS
#27Multimodal chromatography method for the purification of HIV-1 envelope glycoprotein
#28Programmed DNA-driven self-assembled RNA hydrogel
#29Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope
#30Recombinant viral vectors
#31VIRUS LIKE PARTICLE PRODUCTION IN PLANTS
#32Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#33VIRUS LIKE PARTICLE PRODUCTION IN PLANTS
#34Biochemically stabilized HIV-1 Env trimer vaccine
#35Viral vector production system
#36Polyclonal antibodies produced using HIV-1 trimeric envelope glycoprotein subunits
#37Nucleic acid application primers
#38Materials and methods for producing improved lentiviral vector particles
#39Biochemically stabilized HIV-1 Env trimer vaccine
#40Production of soluble HIV envelope trimers in planta
#41Biochemically stabilized HIV-1 env trimer vaccine
#42SCALABLE LENTIVIRAL VECTOR PRODUCTION SYSTEM COMPATIBLE WITH INDUSTRIAL PHARMACEUTICAL APPLICATIONS
#43Avian Cells for Improved Virus Production
#44Method and kit for viral vector isolation
#45Recombinant viral vectors
#46Method for significantly increasing lentiviral production
#47Conformationally Specific Viral Immunogens
#48Anti-Viral Azide Containing Compounds
#49Large commercial scale lentiviral vector production system and vectors produced thereby
#50Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope
#51Buffers for stabilization of lentiviral preparations
#52Biochemically stabilized HIV-1 Env trimer vaccine
#53Method of inducing an immune response against human immunodeficiency virus comprising administering immunogenic compositions comprising authentic trimeric HIV-1 envelope glycoproteins containing a long linker and tag
#54Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#55Serum-free suspension system for lentiviral production
#56Retroviral particle comprising at least two encapsidated nonviral RNAs
#57COCAL ENVELOPE PSEUDOTYPED RETROVIRAL VECTOR PRODUCER CELLS
#58Conformationally specific viral immunogens
#59COMPOSITIONS AND METHODS FOR SPECIFIC REACTIVATION OF HIV LATENT RESERVOIR
#60Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag
#61Materials and methods for producing improved lentiviral vector particles
#62DAGRS: directed antigonists to cancer cell growth signals
#63Anti-viral azide containing compounds
#64Recombinant viral vectors
#65Biochemically stabilized HIV-1 Env trimer vaccine
#66Method for retrovirus removal
#67CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES
#68Lyophilized lentiviral vector particles, compositions and methods
#69COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#70Method for purifying enveloped viruses or viral vectors
#71Live, attenuated vaccines and methods of making and using
#72Vaccine and therapeutic delivery system
#73Approach to produce HIV-1 GP140 envelope protein trimers
#74Approach to produce HIV-1 GP140 envelope protein trimers
#75Method of purifying authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tag
#76Authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag
#77Authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tag
#78Method for producing enveloped viruses
#79Methods of improving titer in transfection-based production systems using eukaryotic cells
#80Recombinant viral vectors
#81Chicken cells for improved virus production
#82HIV therapeutics and methods of making and using same
#83Multiprotein assemblies
#84Method for designing a drug regime for HIV-infected patients
#85Storage stable recombinant lentiviral vector preparation
#86Materials and methods for producing improved lentiviral vector particles
#87Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#88CELL FREE TRANSLATION SYSTEM FOR COMPOUND SCREENING AND RELATED USES
#89MULTIPROTEIN ASSEMBLIES
#90High yield suspension cell line, system, and method for making same
#91Combination anti-HIV vectors, targeting vectors, and methods of use
#92Methods for enhancing infectivity of retroviruses
#93Method for retrovirus removal
#94Biochemically stabilized HIV-1 ENV trimer vaccine
#95ANTI-VIRAL AZIDE-CONTAINING COMPOUNDS
#96Anti-Viral Azide Containing Compounds
#97NOVEL HIV-BASED RECOMBINANT VIRAL CLONES AND USE THEREOF IN ANALYTICAL METHODS
#98MODULATION OF PRODUCTION OF RETROVIRUSES BY APOBEC4
#99Methods of producing an antisense viral particle population
#100VIRAL RECOMBINEERING AND USES THEREOF
#101RECOMBINANT VIRAL VECTORS
#102Method for designing a drug regime for HIV-infected patients
#103Production of Lentiviral Vectors
#104Method of collecting microorganisms using fine particles, method of collecting nucleic acids using fine particles, and kits for use in the these methods
#105Nucleic acids encoding modified South African HIV-1 subtype C gag proteins
#106Simian tropic, recombinant human immunodeficiency-1 viruses
#107Method of Purifying Virus Envelope
#108METHOD AND SYSTEM FOR PROCESSING IMMUNO-COMPETENT CELLS IN VIEW OF AN ANTIVIRAL THERAPY, AND RELATED THERAPEUTIC PROCESS
#109Over-expression of enzymes involved in post-translational protein modifications in human cells
#110Overexpression of enzymes involved in post-translational protein modifications in human cells